News

Non-conformities during routine biomarker testing for lung and colon cancer

Posted 13/12/2018

Dear colleague, 
You are invited to participate in a study to evaluate the frequency of non-conformities during routine biomarker testing for lung and colon cancer.  The aim of this study is to benchmark different non-conformities between institutes in the UK, and to compare them with data that has already been collected from other European institutes. 

All data will be handled anonymously and will be included in a Biomedical Science final year project and a further PhD thesis, as a joint initiative between the University of Leuven in Belgium under the supervision of Prof. Dequeker and the Queen Elizabeth Hospital Birmingham (QEHB), UK under the supervision of Mr. Brendan O'Sullivan.

It would be much appreciated if you could further forward this invitation to others who may be interested in doing so.  The completion of the questionnaire will take no more than 15 minutes.   To start the survey please CLICK HERE

We hope that we can gather representative data from all over the UK and would greatly appreciate it if you would take part in this study. Please do not hesitate to contact us with any questions you might have.

Thank you in advance:
Yann van Royen, Biomedical Science student at University of Leuven, Belgium
Mr. Brendan O'Sullivan, Operations Manager in Molecular Pathology at QEHB
Dr. Philippe Taniere, Consultant Histopathologist at QEHB
Cleo Keppens, PhD student,Biomedical Quality Assurance Research Unit at KU Leuven Belgium
Prof Dequeker, Head of Biomedical Quality Assurance Research Unit at KU Leuven Belgium 

List of GenQA publications

Posted 5/12/2018

For our latest publications go to https://www.genqa.org/publications

BRCA Variant Classification EQA Run 2 Webinar

Posted 23/11/2018

Click HERE to see a webinar presented by GenQA and EMQN on the results of their 2018 BRCA genes variant classification EQA scheme (round 2).
This scheme was sponsored by AstraZeneca.
© Copyright GenQA and EMQN.  This video cannot be copied, distributed or published in any form without the written permission of GenQA or EMQN.

GenQA ISO17043 accreditation maintained

Posted 31/10/2018

We are pleased to announce that GenQA underwent its first joint ISO 17043 accreditation surveillance visit last week which went very well. The accreditation body, UKAS has recommended that our accreditation status be continued and GenQA will continue to provide an accredited service. 

GenQA's most recent accreditation scope may be viewed here: https://www.ukas.com/wp-content/uploads/schedule_uploads/00013/7872Proficiency%20Testing%20Multiple.pdf 

2019 EQA schemes now available

Posted 10/10/2018

Details of the EQA schemes for 2019 are now available at https://www.genqa.org/eqa.  New schemes include:

    • Hereditary breast and ovarian cancer (panel test)
    • Imprinting and UPD (for Angelman syndrome and Beckwith Wiedemann syndrome)
    • Neurofibromatosis (types 1 and 2) and schwannomatosis
    • Osteogenesis Imperfecta
    • Phaeochromocytoma and Paraganglioma disorders (endocrine tumour predispostion and Von Hippel Lindau disease)
    • Retinal disorders
    • Variant validation 
    • X-inactivation

European guidelines for constitutional cytogenomic analysis

Posted 2/10/2018

The European guidelines for constitutional cytogenomic analysis has been published including GenQA authors Dr Ros Hastings and Dr Katrina Rack. 

Please visit https://www.nature.com/articles/s41431-018-0244-x to view the article and https://www.nature.com/articles/s41431-018-0244-x#Sec20 to see a video of Dr Hastings talking about the importance of the guidelines. 

International Workshop on Cancer and Genetic & Cytogenetic Diagnostics

Posted 18/09/2018

March 20 to March 22, 2019

Radboud University Medical Center, Nijmegen, The Netherlands

GenQA's Dr Katrina Rack is an invited speaker, please see here for more information: flyer_program2019.pdf 

Invitation to apply

Posted 18/09/2018

Members of the genomics profession are invited to apply to join the EMQN and GenQA Specialist Advisory Group for Next Generation Sequencing (NGS). In particular individuals with expertise in bioinformatics and statistical analysis are encouraged to apply.

Further information can be found here: Advert for NGS SAG members 2018 v2.pdf

Invitation to participate - BRCA variant run 2

Posted 4/04/2018

Building upon the success of our first BRCA variant classification competence assessment in 2017 (run 1), EMQN and GenQA/UK NEQAS for Molecular Genetics are pleased to announce that registration is NOW OPEN to participate in the 2018 scheme (run 2).

How to participate

Registration is now open and easy to complete.

  • All information including key dates and full instructions on how to complete the EQA will be sent to you.
  • There is no fee to participate as Astra Zeneca will cover your participation costs. Please note that Astra Zeneca will not be provided with your identified EQA results.
  • The closing date is 25th May 2018.


More information may be found here: BRCA variants run 2 - invitation to participate 2018 v3.pdf

Pages

Go to top